Human Papillomavirus and Cervical Preinvasive Disease
Author Information
Author(s): Gheorghe Peltecu, Bari M, Iancu G, Popa F
Primary Institution: Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
Hypothesis
The study investigates the role of HPV in cervical preinvasive disease and the effectiveness of vaccination.
Conclusion
Vaccination against HPV can significantly prevent cervical cancer by protecting against the most aggressive HPV types.
Supporting Evidence
- HPV is responsible for 99.7% of cervical cancer cases.
- The vaccination is recommended for girls aged 11-12.
- Screening has dramatically reduced the incidence of cervical cancer.
- Most HPV infections regress spontaneously, especially in young women.
Takeaway
HPV is a virus that can cause cervical cancer, but we can prevent it with a vaccine, especially for young girls.
Methodology
The study reviews clinical and molecular studies on HPV and cervical cancer, discussing prevention and treatment strategies.
Limitations
The study does not provide specific data on the effectiveness of vaccination in women aged 19 to 26.
Participant Demographics
The study focuses on women, particularly young girls aged 11-12 for vaccination.
Want to read the original?
Access the complete publication on the publisher's website